JSC Atomenergoprom Annual Report
PERFORMANCE IN THE INTERNATIONAL ARENA
JSC ATOMENERGOPROM / ANNUAL REPORT / 54
Jointly with foreign partners, the Company is examining options for the establishment of production and
sales hubs for the construction and subsequent operation of radiopharmaceuticals plants and nuclear
medicine centres.
Foreign customers show strong interest in projects to build nuclear medicine centres and multipurpose
irradiation centres, which are widely used in healthcare and agriculture. Opportunities are being discussed
for the implementation of such projects in Africa, Asia and Latin America, and a number of bilateral project
documents have been signed.
Supply of isotope products
In 2022, JSC Isotope Regional Alliance (a company managed by JSC Atomenergoprom and acting as
ROSATOM's integrator for the exports of isotope products) continued to supply isotope products under
existing contracts and concluded new contracts, despite external and internal restrictions. Considerable
efforts were made to redesign logistics, supply chains and payment arrangements. Preparations continued
for launching Russian radiopharmaceuticals compliant with international GMP standards on the foreign
market.
Promoting life cycle back-end services
The Company is promoting the Balanced NFC, an integrated product for the back end of the nuclear fuel
cycle (NFC), on the global market. This is an offer incorporating certain elements of a closed NFC and
enabling effective recycling of regenerated nuclear materials and a significant decrease in the volume and
radioactivity level of radioactive waste sent for near-surface or medium-depth disposal. This is achieved
through SNF processing and high-level waste fractionation. In addition, in 2022:
Russia and Belarus concluded an intergovernmental agreement on cooperation in SNF management,
which is a necessary prerequisite for concluding a contract for the management of SNF from the
Belarusian NPP;
A contract was concluded and transportation packages were delivered for the management of SNF
from Kudankulam NPP;
The pilot TUK-137T.R transportation package was manufactured; this is new-generation packaging
required for the implementation of the Balanced NFC concept.
Nuclear medicine
In 2022, JSC Atomenergoprom continued to develop its capabilities in the sphere of medicine, produce and
supply medical isotopes and radiopharmaceuticals, and develop medical equipment for diagnostics and
therapy. For instance, following a tender won by JSC National Technical Physics and Automation Research
Institute (NIITFA, an organisation of JSC Atomenergoprom producing medical equipment), a contract was
signed with a Bengal partner to upgrade a gamma radiation facility and supply cobalt-60. Distribution
contracts were concluded for the supply of Russian medical equipment to Mexico and Belarus.
Plans for 2023
Plans for 2023 include the commissioning of power unit No. 2 of the Belarusian NPP.
As part of the Akkuyu NPP construction project in Turkey and the Rooppur NPP construction project in
Bangladesh, in 2023, the Company plans to deliver fresh nuclear fuel to the construction sites.
As part of the El Dabaa NPP construction project, the Company expects to obtain a licence for the
construction of power unit No. 3 and subsequently start the concreting of the foundation slab of the
reactor building at power unit No. 3.
As part of the NRTC construction project in Bolivia, the Company plans to continue construction and
installation operations at stage 4 facilities, including the installation of main process equipment for Bolivia's
first nuclear research reactor.
Given that the customers' interest in the energy market is shifting towards flexible solutions (in terms of
both the power generation volume and the amount of funding), the most important area of focus for the
Company in 2023 will be the promotion of small nuclear power plants. Pre-feasibility studies in Myanmar
and Kyrgyzstan are to be completed. In 2023, the Company plans to agree the Technical Configuration
of the NPP in India with the Indian party and to hand over the pre-feasibility study for small NPPs.
JSC Atomenergoprom plans to consistently diversify its product offer and launch new products on new
markets. In 2023, the Company plans to continue to expand the footprint of its isotope business abroad.
It also plans to be more active on foreign markets in the wind power segment and to leverage existing
capabilities in the Russian Federation. Special emphasis will be placed on the development of projects in
the field of nuclear medicine and energy storage systems, given the considerable potential of these market
segments.
135.9
USD BILLION
10-YEAR PORTFOLIO OF OVERSEAS ORDERS
PERFORMANCE IN THE INTERNATIONAL ARENA
JSC ATOMENERGOPROM / ANNUAL REPORT / 55View entire presentation